VALIANTORGCommodities

Valiant Organics Limited

Specialty Chemicals · ISIN INE565V01010 · BSE 540145 · NSE BE · FV ₹10
Last price
₹408
+5.00%today
What this company does

Valiant Organics Limited operates in Specialty Chemicals, part of the Commodities sector. It booked ₹232 cr of revenue in its latest quarter (Q1 FY27) and kept 12.5% of sales as profit.

The company is one of the world’s largest makers of chlorophenol derivatives, as well as a major Revenue from Operations 7,188 6,772 6.1% local producer of Para Nitro Aniline (PNA).
In the report:
58out of 100
Equitytale Health Score
Mixed

Healthier than 58% of companies in Commodities, on all six measures of filed financials. Each measure is ranked against the 91–173 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
overbought
RSI (14)
80

At close. Not part of the score.

Profitability & returns66

How much profit it earns on the money it employs

Balance sheet42

How much it owes, and whether earnings cover the interest

Cash quality77

Whether reported profit actually arrives as cash

Growth & consistency25

Whether sales and profit have grown, and how steadily

Valuation60

What today's price implies, against our models or its peers

Governance & risk86

How much of the promoters' stake is pledged, and how much they hold

Is this company doing well?
not investment advice
Strengths
Makes a profit
Sales up 13% vs last year
Profit up 254% vs last year
No promoter shares pledged
Strong 15% return on equity
Turns profit into real cash
Watch-outs
None flagged from our data

What if I invest in VALIANTORG?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 0% a year, it would become
₹12.00 lakh

The slider starts at 0%, taken from this company's own free-cash-flow trend. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹408 +5.00%
latest close · 2026-09-17
1-year return
-68.3%
52-wk low ₹25952-wk high ₹1,665
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio9.8Low
LowAverageHigh
P/B ratio1.51Moderate
Below bookModerateHigh
EV / EBITDA7.8Low
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity15.3%Strong
WeakFairStrong ▸15%
Return on capital15.8%Strong
WeakFairStrong
Net margin12.5%Decent
ThinDecentStrong
EBITDA margin19.4%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.33Comfortable
LowModerateHigh ▸1
Interest cover6.8×Strong
RiskyOkayStrong ▸5×
Current ratio1.01Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹1,145 cr
Book value
₹271
EPS
₹10.44
latest quarter
Net debt
₹251 cr
owes more than its cash
Enterprise value
₹1,396 cr
EBITDA
₹180 cr
annualised
EBIT
₹139 cr
annualised
Operating margin
15.0%
Return on assets
9.4%
Earnings yield
10.22%
P/S
1.24
Sales / share
₹330.4
Tax rate
25.4%
Face value
₹10
Shares
2.8 cr
Working capital
₹2 cr
Current assets
₹352 cr
Current liabilities
₹350 cr
Delivery %
41.2%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2025 report & filings
not investment advice
Hard to value confidentlyLow confidence
The market price is far above what these earnings- and book-based models support — a fast-growing or asset-light business can trade well above them for years, so we won't put a confident number on how overpriced it is.
Models span ₹269₹275, midpoint ₹272

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹232 cr
Other Income₹3 cr
Total Income₹235 cr
Cost of Materials₹150 cr
Purchases of Stock-in-Trade₹20.3 L
Inventory Change (±)₹-17 cr
Employee Benefit Expense₹13 cr
Finance Costs₹5 cr
Depreciation & Amortisation₹10 cr
Other Expenses₹43 cr
Total Expenses₹205 cr
Profit before Tax₹30 cr
Tax Expense₹8 cr
Share of JV / Associates₹7 cr
Net Profit₹29 cr
Net margin on total income12.5%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹134 cr55.3%
Employee benefit expense₹13 cr5.4%
Finance costs₹5 cr2.1%
Depreciation & amortisation₹10 cr4.2%
Other expenses₹43 cr17.8%
Tax expense₹8 cr3.1%
Profit for the period₹29 cr12.1%
Total income ₹235 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue159 cr218 cr232 cr
Total income161 cr222 cr235 cr
Expenses158 cr205 cr205 cr
Profit before tax8 cr17 cr30 cr
Tax2 cr2 cr8 cr
Net profit (owners' share)4 cr16 cr29 cr
Net margin (owners' share, on revenue)2.3%7.2%12.5%
EPS (₹)1.305.6110.44
YoY (latest quarter): total income +14.3% · net profit +254.2%
Balance sheet & cash flow · as of Mar 2026
Low debt
Total assets
₹1,231 cr
Shareholder equity
₹759 cr
parent shareholders
Total debt
₹253 cr
Cash
₹2 cr
Cash flow · H1 FY26
Operating
₹92 cr
Investing
₹-70 cr
Financing
₹-23 cr
Peer comparison
Specialty Chemicals · by market value
CompanyPriceMarket capP/E
Pidilite Industries Limited₹1,552₹1.58 L cr45.3
Gujarat Fluorochemicals Limited₹4,472₹49,190 cr55.4
Navin Fluorine International Limited₹8,220₹42,169 cr43.3
Deepak Nitrite Limited₹1,605₹21,889 cr15.9
Aether Industries Limited₹1,623₹21,543 cr85.1
Atul Limited₹6,134₹18,057 cr18.4
Aarti Industries Limited₹477₹17,287 cr27.9
Fine Organic Industries Limited₹5,202₹15,949 cr28.9
BASF India Limited₹3,602₹15,591 cr11.2
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
trailing 12 months
Dividend / share (TTM)
Last dividend
₹1
ex 10 Feb 2023
ActionDetailEx-date
Dividend₹1 / share10 Feb 2023
Dividend₹3.5 / share20 Sep 2022
Bonus issue1:124 Dec 2020
Dividend₹5 / share24 Nov 2020
Dividend₹6 / share11 Mar 2020
Dividend₹5 / share20 Nov 2019
Who owns it · 2026-06-30
No pledge
Promoter
37.9%
FII / Foreign
0.2%
DII / Domestic
Retail / others
61.9%
Smart-money activity
Insider trades
BoughtVicky Hemchand Gala · Promoter3,500 · ₹38115 Sep 26
BoughtVicky Hemchand Gala · Promoter3,500 · ₹13.3 L15 Sep 26
BoughtSiddharth Dinesh Shah HUF · Designated Person1,000 · ₹3.3 L7 Sep 26
Bulk / block deals
BoughtNK SECURITIES RESEARCH PRIVATE LIMITED · NSE1.68 L @ ₹258.9919 Mar 26
SoldNK SECURITIES RESEARCH PRIVATE LIMITED · NSE1.68 L @ ₹259.2819 Mar 26
BoughtGRAVITON RESEARCH CAPITAL LLP · NSE1.67 L @ ₹466.8123 Mar 23
Stake changes
SoldVicky Hemchand Gala · promoter→ 1.03% · 12,14020 Feb 24
DisposalArti Gogri · promoter→ 7.29%3 Mar 22
BoughtMirik Rajendra Gogri · promoter→ 2.46% · 1.63 L3 Mar 22
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 26 Sep 2025
See the official result
1
To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025 together with the Reports of the Board of Directors’ and the Auditors’ thereon.
Backed by 100% of shareholders other than promotersneeded 50%
84.68 L votes for, 225 against · 0% of mutual funds and other big investors said no
2
To appoint a Director in place of Shri Mahek M. Chheda (DIN: 06763870) who is liable to retire by rotation and being eligible, offers himself for re-appointment.
Backed by 100% of shareholders other than promotersneeded 50%
84.68 L votes for, 795 against · 0% of mutual funds and other big investors said no
3
To appoint a Director in place of Dr. Kiritkumar H. Desai (DIN: 08610595) who is liable to retire by rotation and being eligible, offers himself for re-appointment
Backed by 100% of shareholders other than promotersneeded 50%
84.67 L votes for, 960 against · 0% of mutual funds and other big investors said no
4
To appoint Secretarial Auditor of the Company.
Backed by 100% of shareholders other than promotersneeded 50%
84.68 L votes for, 85 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 35 named members
owning 37.9% between them · as of 2026-06-30
Jaya Chandrakant Gogri8.24%
Arti Rajendra Gogri7.05%
Manisha Rashesh Gogri5.67%
Dilesh Roadlines Pvt Ltd2.85%
Mirik Rajendra Gogri2.39%
Tulip Family Trust (Gloire Trusteeship Services Private Limited)2.18%
Ujjwal Business Trust (Alabhya Trusteeship Private Limited)2.14%
Arvind Kanji Chheda1.55%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.